Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NNC0497-0040 in Healthy Participants, Overweight/Obesity, and Type 1 Diabetes
NCT07578584Phase 1Recruiting
- Sponsor
- Novo Nordisk
- Start
- May 2026
- Primary completion
- Feb 2028
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of NNC0497-0040 in Overweight, obesity and type 1 diabetes mellitus (T1D) (5 arms), sponsored by Novo Nordisk. Primary endpoint: Number of adverse events. Started May 2026; status: recruiting.
02
Drugs
NNC0497-0040
03
Conditions
Overweightobesitytype 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07578584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07578584.